Marcaine is a brand name of bupivacaine, approved by the FDA in the following formulation(s):
MARCAINE (bupivacaine hydrochloride - injectable; spinal)
Manufacturer: HOSPIRA
Approval date: May 4, 1984
Strength(s): 0.75% [RLD][AP]
Has a generic version of Marcaine been approved?
Yes. The following products are equivalent to Marcaine:
SENSORCAINE (bupivacaine hydrochloride injectable; spinal)
Manufacturer: APP PHARMS
Approval date: April 15, 1987
Strength(s): 0.75% [AP]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Marcaine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Marcaine.
See also...
- Marcaine Solution Consumer Information (Wolters Kluwer)
- Bupivacaine Solution Consumer Information (Wolters Kluwer)
- Bupivacaine in Dextrose Solution Consumer Information (Wolters Kluwer)
- Bupivacaine Consumer Information (Cerner Multum)
- Bupivacaine Hydrochloride AHFS DI Monographs (ASHP)
No comments:
Post a Comment